Tenofovir DF

Fidelia Bernice, Pharm.D., BCIDP
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS
Tenofovir DF is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

  1. Treatment of HIV-infection in adults and pediatric patients (≥2 years of age, weighing ≥10 kg) in combination with other antiretroviral drugs.
  2. Treatment of HBV in adults and pediatric patients ≥2 years of age, weighing ≥10 kg

NON-FDA APPROVED USES

  • Treatment of hepatitis in HIV-HBV co-infected pts.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

  1. Treatment of HIV-infection in adults and pediatric patients (≥2 years of age, weighing ≥10 kg) in combination with other antiretroviral drugs.
  2. Treatment of HBV in adults and pediatric patients ≥2 years of age, weighing ≥10 kg

NON-FDA APPROVED USES

  • Treatment of hepatitis in HIV-HBV co-infected pts.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: January 14, 2021